Intravenous glucose therapy to mother prior to delivery significantly affects glucose and insulin homeostasis in fetus and newborn infants. Specifically, the infants show hyperglycemia, and hyperinsulinism at birth, and are predisposed to hypoglycemia in the first few hours of life. In this paper we have focussed attention on the clinical significance of these changes and suggest some remedial measures, in light of our own research.